Publications by authors named "Alejandro Villalba"

Claim this Profile
E
Expanded blood PD-1hi Tfh cells in seropositive clinically suspect arthralgia predict progression to rheumatoid arthritis.
Laura Nuño, Beatriz Nieto-Carvalhal, Mariana Gutiérrez-Riart, Marta Novella-Navarro, Diana Peiteado, Alejandro Villalba

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis.
Marta Novella-Navarro, Laura González-Sánchez, Borja Hernández-Breijo, Rebeca Pérez De Diego, Pilar Sánchez-Corral, Alejandro Villalba

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transiently increased circulating CD39+FoxP3+ Treg cells predicts the clinical response to methotrexate in early rheumatoid arthritis.
Alejandro Villalba, Laura Nuño, Marta Benito-Miguel, Beatriz Nieto-Carvalhal, Irene Monjo

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis.
Irene Monjo-Henry, Mariela Uyaguari, Laura Nuño, Beatriz Nieto-Carvalhal, Elisa Fernández-Fernández, Alejandro Villalba

Rheumatology (Oxford)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases.
Ana Martínez-Feito, Marta Novella-Navarro, Borja Hernández-Breijo, Pilar Nozal, Diana Peiteado, Alejandro Villalba

Rheumatology (Oxford)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Marta Novella-Navarro, Virginia Ruiz-Esquide, Natalia López-Juanes, Chafik Alejandro Chacur, Irene Monjo-Henry, Alejandro Villalba

Clin Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment.
Marta Novella-Navarro, JoséLuis Cabrera-Alarcón, Natalia López-Juanes, Alejandro Villalba, Elisa Fernández Fernández

RMD Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'.
Marta Novella-Navarro, Chamaida Plasencia-Rodríguez, Carolina Tornero, Victoria Navarro-Compán, José Luis Cabrera-Alarcón, Alejandro Villalba

Ann Rheum Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis.
Marta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide, Carolina Tornero, Mariana Díaz-Almirón, Alejandro Villalba

Ther Adv Musculoskelet Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.
Diego Benavent, Karen Franco-Gómez, Chamaida Plasencia-Rodriguez, Marta Novella-Navarro, Patricia Bogas, Alejandro Villalba

BMJ Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients.
Oscar J Cordero, Irene Viéitez, Irene Altabás, Laura Nuño-Nuño, Alejandro Villalba

Arch Immunol Ther Exp (Warsz)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis.
Sara Fuentelsaz-Romero, Celia Barrio-Alonso, Raquel García Campos, Mónica Torres Torresano, Ittai B Muller, Alejandro Villalba

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies.
Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, Ana M Ortiz, Alejandro Villalba

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
Laura Nuño, Marta Novella Navarro, Gema Bonilla, Karen Franco-Gómez, Pilar Aguado, Alejandro Villalba

Ann Rheum Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis.
Marta Novella-Navarro, Chamaida Plasencia, Carolina Tornero, Victoria Navarro-Compán, José L Cabrera-Alarcón, Alejandro Villalba

Arthritis Res Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies.
Lorena Rodriguez-Martínez, Holger Bang, Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, Alejandro Villalba

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis.
Paula Fortea-Gordo, Alejandro Villalba, Laura Nuño, María José Santos-Bórnez, Diana Peiteado

Rheumatology (Oxford)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis.
Cristina Regueiro, Luis Rodriguez-Rodriguez, Raquel Lopez-Mejias, Laura Nuño, Ana Triguero-Martinez, Alejandro Villalba

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis.
Cristina Regueiro, Luis Rodriguez-Rodriguez, Raquel Lopez-Mejias, Laura Nuño, Ana Triguero-Martinez, Alejandro Villalba

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics.
Cristina Regueiro, Lorena Rodríguez-Martínez, Laura Nuño, Ana M Ortiz, Alejandro Villalba

Arthritis Res Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis.
Paula Fortea-Gordo, Laura Nuño, Alejandro Villalba, Diana Peiteado, Irene Monjo

Rheumatology (Oxford)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Golimumab Tapering Strategy Based on Serum Drug Levels in Patients With Spondyloarthritis.
Cristina Redondo, Ana Martínez-Feito, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, Laura Nuño-Nuño, Alejandro Villalba

Arthritis Rheumatol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents.
María-Belén Bautista-Caro, Eugenio de Miguel, Diana Peiteado, Chamaida Plasencia-Rodríguez, Alejandro Villalba

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.
Cristina Regueiro, Laura Nuño, Ana M Ortiz, Diana Peiteado, Alejandro Villalba

Sci Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients.
Jurado Teresa, Plasencia-Rodríguez Chamaida, Martínez-Feito Ana, Navarro-Compán Victoria, Rispens Theo, Villalba Alejandro

Open Rheumatol J· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis